Randomized controlled comparative trial between low dose dexmedetomidine sedation and that of fentanyl in children after surgical procedures in surgical Pediatric Intensive Care Unit  by Saleh, Riham Hussein
Egyptian Journal of Anaesthesia (2016) 32, 137–142HO ST E D  BY
Egyptian Society of Anesthesiologists
Egyptian Journal of Anaesthesia
www.elsevier.com/locate/egja
www.sciencedirect.comResearch ArticleRandomized controlled comparative trial between
low dose dexmedetomidine sedation and that of
fentanyl in children after surgical procedures in
surgical Pediatric Intensive Care Unit* Address: Department of Anaesthesiology, Cairo University, Egypt. Mobile: +20 1223938549.
E-mail address: rhsaleh@yahoo.com.
Peer review under responsibility of Egyptian Society of Anesthesiologists.
http://dx.doi.org/10.1016/j.egja.2015.08.003
1110-1849  2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.Riham Hussein Saleh *Department of Anaesthesiology, Cairo University, EgyptReceived 23 June 2015; revised 26 July 2015; accepted 5 August 2015
Available online 20 October 2015KEYWORDS
Dexmedetomidine;
Fentanyl;
Surgical pediatric patients;
SedationAbstract Background: Children undergoing different surgical procedures and requiring
postoperative ventilation need intense analgesia and sedation. This was done using opioids and
benzodiazepines with their common side effects as respiratory depression and prolonged sedation.
Aim of the study: To study the efficacy of sedation and time taken form stopping the infusion
to extubation using low dose of dexmedetomidine compared with fentanyl sedation in
post-operative Pediatric surgical Intensive Care Unit (PICU).
Patients and Methods: A randomized double-blind study involving 50 children undergoing
different surgical procedures was performed. The patients were equally divided into two groups,
each including 25 patients. One group sedated with fentanyl at 1 lg/kg/h (Fen Group) and the other
group sedated with dexmedetomidine at 0.3 lg/kg/h (Dex Group) for 18 h post-operatively with
intermittent rescue fentanyl 0.5 lg/kg bolus in the 2 groups as required during endotracheal
suctioning. The depth of sedation was assessed using the Ramsay sedation score, the tracheal
suctioning score and pediatric intensive care unit sedation score. The time taken from
discontinuation of infusion till extubation was recorded.
Results: All sedation scores in the fentanyl and dexmedetomidine groups were comparable.
Hemodynamic parameters were comparable between the two groups. Average time (in minutes)
required for extubation after stopping the infusions was 136.2 (±54.2 SD) in the Dex group
compared with 341.4 (±125.4 SD) in the Fen group. The difference in mean time for extubation
was statistically significant. Conclusions: Low dose dexmedetomidine provides adequate sedation
for mechanically ventilated children and also early extubation as compared with fentanyl.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
138 R.H. Saleh1. Introduction
Pediatric patients in surgical ICU (SICU) require sedation and
analgesia, especially if mechanically ventilated, where frequent
suctioning is required. Opioids and benzodiazepines are com-
monly used in Surgical ICU to provide optimum sedation
and prevent accidental extubation, in spite of their common
side effects e.g. respiratory depression and delayed arousal
after the end of the infusion [1].
Dexmedetomidine provides sedation with analgesia through
its hypnotic effect and similarity to natural sleep. Central
Nervous System (CNS) stimulation of parasympathetic
outflow and inhibition of sympathetic outflow from the locus
coeruleus in the brain stem plays an important role in sedation
and anxiolysis [2]. There are dose dependant bradycardia and
hypotension, with doses higher than 0.4 lg/kg [3].
The wide margin of safety of the drug is attributed to its
limited respiratory depression effects, with high levels of
sedation [4,5].
Dexmedetomidine, alpha2 adrenoceptor agonist, has been
used in pediatrics for sedation during variety of clinical situa-
tions as non-invasive radiology procedures. Dexmedetomidine
has minimal respiratory depressant effects, which makes it the
drug of choice as an adjuvant drug for analgesia and sedation
in pediatric ICU. It has also a role in preventing postanesthesia
emergence delirium and shivering. The loading dose ranges
from 0.5 to l lg/kg over 10 min followed by infusion dose of
0.2–5 lg/kg/h [6].
Infusion of Dexmedetomidine makes the patients sedated
and easily arousable with hypnosis similar to natural Non-
rapid Eye Movement (NREM) sleep [2].
Omitting the loading dose and minimizing the infusion
doses to less than 0.4 lg/kg may avoid the occurrence of
hypotension and bradycardia [3].
The alpha2 adrenergic agonist, dexmedetomidine, is used in
children to produce sedation during radiological procedures,
to produce controlled hypotension to decrease intra-
operative blood loss and to produce sedation during mechan-
ical ventilation in ICU [7].
Dexmedetomidine infusion at 0.3 lg/kg/h is an effective
and well tolerated drug for both mechanically ventilated and
spontaneously breathing pediatric patients after cardiac cor-
rection surgery. Hypotension and bradycardia were observed
with increasing the doses but return back to normal shortly
after discontinuation of the infusion [8].
Dexmedetomidine is having good analgesic effects in the
postoperative period, reducing morphine requirements by up
to 50%, with no adverse effects on respiratory rate, oxygen
saturation, arterial partial carbon dioxide tension and arterial
pH [9].
The use of different types of opioids via variable roots is
associated with dose dependent respiratory depression [10].
Dexmedetomidine, when compared with other sedatives,
has both sedative and analgesic effects, reduces agitation and
delirium, and has no respiratory depression and minimal
cardiovascular effects [11].
It declines noradrenergic output from the locus coeruleus
and allows increase in firing of inhibitory neuron (GABA).
Centrally acting alpha2 adrenergic agonists also activatecentral sympatholytic effects, leading to decrease in heart rate
and blood pressure. Primary analgesic effects and the increase
of opioid-induced analgesia result from the stimulation of
alpha2 adrenergic receptor in the dorsal horn of the spinal
cord and decrease of substance P release [11,12].2. Aim of the study
In this study we compare the efficacy of sedation and time
required for extubation for mechanically ventilated children
during low dose dexmedetomidine infusion in surgical PICU
with that of fentanyl.
3. Patients and methods
This study was performed in Abo-Elreesh teaching hospital
and surgical PICU from September 2013 till December 2014,
on 50 children, aged 1–10 years, ASA I&II. After approval
from the ethical committee, informed consents were taken
from the parents of 50 children to share in this randomized
double blinded study. The children were equally divided into
2 groups 25 each, and randomization was done by the closed
envelop method. One group sedated with fentanyl at
1 lg/kg/h (Fen Group) and the other group sedated with
dexmedetomidine at 0.3 lg/kg/h (Dex Group) for 18 h
post-operatively.
Inclusion criteria were pediatric patient’s age group
1–10 years scheduled for abdominal surgery in whom
overnight ventilation was anticipated (e.g. huge Hirrsprung’s
disease, intestinal resection and diaphragmatic hernia with
mechanical compression of the lungs).
Exclusion criteria include patients younger than 1 year,
emergency surgeries, patients with severe liver dysfunction,
because there is precaution to use Dexmedetomidine in hepatic
patients and patients requiring ventilation more than 24 h, to
allow us to stop the sedation infusion after 18 h and record
the time for extubation.
Preoperative sedation was given to all the patients with
intramuscular midazolam 0.1 mg/kg and atropine 0.02 mg/kg.
Induction of anesthesia was done with propofol 3 mg/kg
intravenously, after fixation of an intravenous cannula,
followed by atracurium 0.5 mg/kg to facilitate endotracheal
intubation and fentanyl 2 lg/kg. Anesthesia was maintained
with sevoflurane 1 MAC and atracurium at intervals of
20 min.
At arrival to the SICU immediately either dexmedetomidine
infusion at a dose of 0.3 lg/kg/h (Dex group) or fentanyl
1 lg/kg/h (Fen group) was started by an anesthesiologist,
who is not involved in the study and unaware of the infused
drugs [3,13].
The study observer was not aware of the infusion drugs
given to the patients of both groups. The infusion was main-
tained to the next day and then stopped (see Fig. 1).
The sedation scores such as Ramsay sedation score (RSS),
tracheal suctioning score (TSS), Pediatric Intensive Care Unit
(PICU) sedation score, and hemodynamic parameters were
monitored hourly and recorded at 1, 4, 10, 18 and 24 h
respectively [14,15].
Assessed for eligibility (n=73)
Excluded (n=23)
♦ Not meeting inclusion criteria (n=16)
Required ventilation >24 hrs (n=10)
Age less > 1yr (n=6)
♦ parent's refusal (n=7 )
Analysed (n=25)
♦ Excluded from analysis (n=0)
Follow-up for 24 hours (n=25)
Discontinued intervention (n=0)
Dex group (n=25)
♦ Received Dexmedetomidine 0.3 ug/kg/hr for 
18 hours in pediatric intensive care unit 
postoperatively  (n=25 )
Follow-up for 24 hours (n= 25)
Discontinued intervention (n= 0)
Fen group (n=25)
♦ Received Fentanyl 1 ug/kg/h for                  
18 hours in pediatric intensive care unit 
postoperatively (n= 25)
Analysed (n=25)
♦ Excluded from analysis (n= 0)
Allocation
Analysis
Follow-Up
Randomized (n= 50)
Enrollment
Figure 1 CONSORT flowchart of the study.
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3.1.1. Modified Ramsay sedation score (RSS)
1. Anxious, agitated, restless.
2. Eye opened, cooperative, oriented, tranquil.
3. Response (opens eyes) to commands, light touch, normal
tone of voice.
4. Brisk response to light glabellar tap or loud voice/noise.
5. Sluggish response to light glabellar tap or loud voice/
noise.
6. No response to light glabellar tap or loud voice/noise.
3.1.2. Tracheal suctioning score (TSS)
1. Patient is restless or distressed when not disturbed.
2. Patient is awake and moving, but not distressed if left
alone.
3. Movement only with nursing care, major limb movement/
distressed with tracheal suctioning.
4. Cough, grimace or minor limb movement with suctioning.
5. No response to tracheal suctioning.3.1.3. Pediatric Intensive Care Unit (PICU) sedation score
1. Awake, alert.
2. Occasionally drowsy, easy to arouse.
3. Frequently drowsy, easy to arouse.
4. Somnolent.
Adequate sedation was met with Ramsay scores of 4 or 5,
TSS of 3 or 4 and PICU score of 3. Inadequate sedation was
defined as Ramsay scores of 2 or 3, TSS of 1 or 2 and PICU
score of 1 or 2, and to those patients 0.5 lg/kg fentanyl was
given as rescue sedation in both groups. The sedation infusion
was discontinued after 18 h. The time elapsed from stopping
the infusion till extubation was recorded.
Extubation criteria include (1) hemodynamic stability, (2)
normothermia, (3) awake state, (4) spontaneous breathing at
the age appropriate rate, and(5) normocarbia with less than
10 cm H2O pressure support. When those criteria are met
patients were ready for weaning from ventilation and extuba-
tion was done and nasal cannula with supplemental oxygen
was applied.
Hemodynamic compromise severity was classified into
3 degrees as follows:
140 R.H. Saleh(1) mild: requires no intervention,
(2) moderate: requires reduction of the dose.
(3) sever: requires discontinuation of the infusion.
3.2. Statistical analysis
A power analysis revealed that 25 patients in each group would
be demanded to provide 80% power to detect a significant dif-
ference between the 2 studied groups. Statistical analysis was
performed using SPSS version 10.0 (SPSS ltd, Chicago, IL,
U.S.A.). Values are presented as mean (SD) or number (%).
Hemodynamic data (as HR and BP) were analyzed using
one way analysis of variance (ANOVA) for comparisons
between different groups and multiple way ANOVA for com-
parisons of within group changes. Ordinal categorical data
such as sedation scores and need for additional sedation were
analyzed with Chi Square test or Fisher’s exact test. Nominal
categorical data such as gender, type and duration of surgery
were also analyzed with the Chi Square test or Fisher’s exact
test. A p value <0.05 was considered to be statistically
significant.
4. Results
The demographic data of the two groups (Fen group and Dex
group) were comparable. There was no statistically significant
difference in the duration of surgery as seen in Table 1.
The average duration of sedation was around 18 h in both
groups. There was no statistically significant difference in the
requirement of rescue sedation between the two groups as seen
in Table 1.
The average time for extubation after cessation of the seda-
tive infusion was 136.2 ± 54.2 min in the Dex group as com-
pared with 341.4 ± 125.4 min in the Fen group, with a P
value of <0.001 (statistically significant) as shown in Table 2.Table 1 Demographic data of the two groups.
Fen group Dex group
Age (years) 5.68 (±2.4) 6.12 (±2.9)
Sex (females/males) 14/11 13/12
Surgery duration (min) 103.3 (±18.6) 100.4 (±20.1)
Duration of sedation (h) 18 18
Rescue sedation (lg) 3.75 (±0.12) 3.64 (±0.14)
Table 2 Descriptive analysis of the time for extubation
between the two groups.
Fen group Dex group
Time for extubation (mini–max) in
min
210–390 85–265
Median time for extubation
(in min)
300 175
Mean time for extubation in min
(SD)
341.4
(±125.4)
136.2
(±54.2)**
** Highly significant (P value <0.001).There was no statistical as well as clinically significant dif-
ference in the hemodynamic parameters, i.e. the pulse, systolic
blood pressure and diastolic blood pressure, between the two
groups.
Even though the heart rate decrease in the Fen group in the
first few hours, was <7% to 10% of baseline and did not
require any intervention, there was no significant hypotension
in either group.
Sedation scores measured at 1, 4, 10, 18 and 24 h, between
the two groups were comparable, with no accidental extuba-
tion from inadequate sedation. The median with interquartile
range of RSS, TSS and PICU sedation score in the Fen and
Dex groups was comparable, as shown in Table 3.5. Discussion
In pediatric surgical intensive care unit (PSICU) mechanical
compression of the lungs from diaphragmatic defects, as in
diaphragmatic hernia repair or huge intestinal dilatations, as
in Hirrsprung’s disease, when postoperative ventilation is
required [7].
Patients require sedation and analgesia to tolerate mechan-
ical ventilation and to prevent inadvertent extubation.
Dexmedetomidine by its CNS inhibitory effect on sympathetic
outflow from locus coeruleus in the brain stem produces seda-
tion and analgesia [2,5].
The associated decrease in blood pressure and heart rate is
due to its sympatholytic effects, and is dose dependent [11].
Dexmedetomidine has minor effect on respiration and,
therefore, allows early extubation, [11,13,16] whereas in case
of fentanyl, being an opioid, the respiratory depressant effect
is the most prominent causing delayed extubation. [17,18].
In this study, we compared the analgesic fentanyl-based
sedation (most common agent used in the post-operative inten-
sive care unit because of its hemodynamic stability) with the
sedation of the central alpha2 agonist dexmedetomidine; using
the RSS, PICU score and TSS as shown in Table 3.
In this study, there was a highly significant delay in extuba-
tion in the Fen group, the average time being (341.4
± 125.4 min) as compared with Dex group time (136.2
± 54.2 min).
This is in line with a retrospective study with post-operative
dexmedetomidine infusion in pediatric patients undergoing
cardiac surgery. Dexmedetomidine was administered in the
post-operative unit at a dose of 0.1–0.5 lg/kg/h for 3–26 h,
and the investigators reported successful post-operative
sedation in 93% of the patients with absent or minimal pain
scores. They also reported that 87% of the patients on
dexmedetomidine infusion were easily weaned and extubated
[16].
Tobias and Berkenbosch [13] in a prospective randomized
study showed that dexmedetomidine at 0.5 lg/kg/h provides
more effective sedation and decreased the rescue doses of
morphine.
In this study, the sedation in the Dex group was adequate
and comparable with the Fen group; the rescue doses of fen-
tanyl required were comparable in both the groups.
In the recent study, the hemodynamic effects were minimal
and did not require any intervention. This was probably due to
the avoidance of an initial loading dose and also a low infusion
dose of 0.3 lg/kg/h in the Dex group [3].
Table 3 Sedation scores in the ICU in postoperative period between the two groups [median (interquartile range)].
Fen group Dex group
Time (h) 1 4 10 18 24 1 4 10 18 24
Modified Ramsay Sedation Score 6(1) 5(2) 4(2) 4(2) 3(1) 6(1) 5(1) 5(2) 4(1) 3(1)
Tracheal suctioning score 5(2) 4(2) 4(1) 3(1) 2(1) 5(2) 4(1) 3(1) 3(1) 2(1)
Pediatric Intensive Care Unit score 4(1) 4(2) 3(1) 2(1) 2(1) 4(1) 4(1) 3(1) 3(1) 2(1)
Randomized controlled comparative trial between low dose dexmedetomidine sedation 141Petroz et al. [12] in a two-center study of pharmacokinetic
and pharmacodynamics of dexmedetomidine in children at
doses of 2, 4 and 6 lg/kg/h showed that heart rate and systolic
blood pressure decreased modestly (<15% and <25%,
respectively) during the first hour after dexmedetomidine
infusion. The magnitude of decrease in heart rate and blood
pressure was proportional to the increase in the dose of
dexmedetomidine. At lower doses, the decrease was of modest
clinical interest and did not need corrective action.
Bloor et al. [19] and Tobias [11] in their experience with
dexmedetomidine found that the potential adverse cardiac
and hemodynamic effects of dexmedetomidine, such as
bradycardia, sinus arrhythmia and hypotension, occur with
the initial loading doses. This is why we preferred to omit
the loading dose of dexmedetomidine sedation to prevent
any hemodynamic effects in children.
In a study on the effects of increasing doses of dexmedeto-
midine in children 2, 4, 6 lg/kg/h was infused for 10 min, sys-
tolic blood pressure and heart rate decreased respectively,
sedation was transiently maintained and respiratory responses
were the same [20].
Dexmedetomidine infusion of 1 lg/kg/min for 10 min
may produce sedation as long as 4 h after the stoppage
of the infusion, but hemodynamic stability was mentioned
[21].
In a prospective randomized trial in pediatric intensive care
midazolam infusion (0.l mg/kg/h) was compared with
dexmedetomidine infusion of 0.25 lg or 0.5 lg/kg/h, respec-
tively. They concluded that dexmedetomidine at a dose of
0.5 lg/kg/h provides better sedation seen with the Ramsay
sedation score and the bispectral index and decreases the need
for narcotics [22].
Venn et al. [23] in a randomized study showed that
dexmedetomidine at an initial loading dose of 1 lg/kg/h over
10 min followed by maintenance dose of 0.7 lg/kg/h provided
optimal sedation, but 18 of 66 patients had adverse hemody-
namic effects in the form of hypotension or bradycardia, and
in 11 of 18 patients the hemodynamic effects were during load-
ing infusion.
Park et al. [24] compared hypnotic-based sedation using
propofol and/or midazolam with analgesia-based sedation
using remifentanil in a general intensive care unit, and found
that analgesia-based sedation provided more satisfactory seda-
tion during mechanical ventilation and also allowed early extu-
bation as compared with hypnotic-based sedation.
Muellejans et al. [25] compared remifentanil versus fentanyl
for analgesia-based sedation in the intensive care unit and
concluded that analgesia-based sedation with fentanyl or
remifentanil was comparable and helped in early extubation
of the patients.6. Conclusion
Dexmedetomidine in a low dose (0.3 lg/kg/h) provides compa-
rable sedation and stable hemodynamic effects such as that
produced by fentanyl. With minimal depression of the respira-
tory system and sleep-like sedation Dexmedetomidine provides
early extubation and can replace fentanyl in pediatric patients
postoperatively.
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